JPS6399094A - Dammarane compound - Google Patents

Dammarane compound

Info

Publication number
JPS6399094A
JPS6399094A JP22887987A JP22887987A JPS6399094A JP S6399094 A JPS6399094 A JP S6399094A JP 22887987 A JP22887987 A JP 22887987A JP 22887987 A JP22887987 A JP 22887987A JP S6399094 A JPS6399094 A JP S6399094A
Authority
JP
Japan
Prior art keywords
compound
cellulase
saponin
methanol
stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP22887987A
Other versions
JPH0368040B2 (en
Inventor
Shigenobu Arihara
Shinichi Hayashi
Kiju Nishimoto
Toshio Odajima
Noriko Takagi
Tsunematsu Takemoto
Yoshie Watanabe
Original Assignee
Rooto Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rooto Seiyaku Kk filed Critical Rooto Seiyaku Kk
Priority to JP22887987A priority Critical patent/JPH0368040B2/ja
Publication of JPS6399094A publication Critical patent/JPS6399094A/en
Publication of JPH0368040B2 publication Critical patent/JPH0368040B2/ja
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Abstract

NEW MATERIAL:The compound of formula (glu is β-glucopyranosyl group).
USE: A carcinostatic agent.
PREPARATION: The compound of formula can be produced e.g. by (1) dissolving whole saponin of Gynostemma pentaphyllum containing 2-α-hy droxyprotopanaxadiol saponin as main component in an aqueous solution of dihydrogen sodium phosphate or 4.0 pH, (2) stirring the mixture in the presence of a cellulase at 37°C for 24hr, (3) stirring for 6 days after the addition of aque ous methanol and cellulase, (4) passing the reaction liquid through an adsorbent column, (5) eluting the adsorbed component with methanol and (6) purifying the eluate by silica gel column chromatography.
COPYRIGHT: (C)1988,JPO&Japio
JP22887987A 1987-09-11 1987-09-11 Expired - Lifetime JPH0368040B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22887987A JPH0368040B2 (en) 1987-09-11 1987-09-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22887987A JPH0368040B2 (en) 1987-09-11 1987-09-11

Publications (2)

Publication Number Publication Date
JPS6399094A true JPS6399094A (en) 1988-04-30
JPH0368040B2 JPH0368040B2 (en) 1991-10-25

Family

ID=16883293

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22887987A Expired - Lifetime JPH0368040B2 (en) 1987-09-11 1987-09-11

Country Status (1)

Country Link
JP (1) JPH0368040B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002003996A1 (en) * 2000-07-12 2002-01-17 RAJKUMAR, Sujatha Use of dammarane-type tritepenoid saporins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002003996A1 (en) * 2000-07-12 2002-01-17 RAJKUMAR, Sujatha Use of dammarane-type tritepenoid saporins

Also Published As

Publication number Publication date
JPH0368040B2 (en) 1991-10-25

Similar Documents

Publication Publication Date Title
JPS58140026A (en) Pharmaceutical having improved absorbability
DK165839C (en) Tigogenin cellobiosidforbindelser, to pharmaceutical compositions containing the compounds, use of said compounds for the preparation of a pharmaceutical composition and processes for preparing the compounds
DK164408C (en) Growth hormone releasing factor compounds, the compounds for use as a therapeutic agent, processes for preparing the compounds, to pharmaceutical compositions containing an effective amount of such a compound and the use of the compound
INOUE et al. Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase
JPS57183712A (en) Removing method of pyrogen
PT84359A (en) Process for the preparation of granules containing an active substance and to the use thereof as speckles for treating substrates
JPH03135992A (en) Crystal2-o-alpha-d-glucopyranosyl-l-ascorbic acid, production and use thereof
JPS60184013A (en) Eye drop
JPS60136512A (en) Remedy and preventive for hyperlipemia
Walterova et al. Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids
JPH02288888A (en) Teichomycin a2 pure single factor-4
Levine Analysis of acetylsalicylic acid and acetylsalicylic acid tablets
Akparov et al. Phenylboronic acid as a ligand for biospecific chromatography of serine proteinases
McLennan et al. The chromatographic behaviour of the acetylcholine activity of brain extracts
JPS6048924A (en) Remedy for osteoporosis
RU95112485A (en) Process for 9-aminocamptotecin intermediate compounds, process for preparation of thereof, pharmaceutical composition
JPS57183756A (en) Preparation of 4-hydroxy-2-pyrrolidone
CA2059979A1 (en) Complex containing coagulation factor ix
Moule et al. Relationships between the chemical structure and the biological properties of some eremophilane compounds related to PR toxin
JO1406B1 (en) Chemical compounds
JPS5777697A (en) Physiologically active substance nsq
JPH02218663A (en) New proline derivative
DK378988D0 (en) The dopamine beta-hydroxylase inhibitors, process for their preparation and to pharmaceutical compositions containing these compounds
JPS5916818A (en) Solution for fluid therapy by administration through vein
JPS60243017A (en) Antispasmodic composition